About this role
Let’s build the future of medicine - together.
Join Enveda in Clinical Development for Migraine on a Contract basis and help us transform natural compounds into life-changing medicines. We’re a team driven by curiosity and innovation - are you ready to make a difference?
Remote | Contract | $275-$350/hr |
What Makes Us Enveda
Life is smart, and we can learn from it. We’re reinventing drug discovery by harnessing nature’s intelligence. Our platform identifies new medicines four times faster than the industry standard because patients can’t wait. What sets Enveda apart isn’t just what we do - it’s how we do it. Our culture is built on creativity, collaboration, and deep respect for each other. We believe “People Create All Value”, and our success is driven by the extraordinary team turning our mission into reality every day.
Our Momentum
- Unicorn status: Achieved following a $150 million Series D funding round in 2025
- Discovery and innovation: Advanced our first drug candidate to Phase 1 trials in 2024
- Award-winning culture:
- Newsweek: Top 100 Global #MostLovedWorkplaces (2025)
- Forbes: America’s Best Startup Employers (2024 & 2025)
- Newsweek: America’s Greatest Startup Workplaces (2025)
- Fast Company: Most Innovative Companies in 2026
These milestones reflect the impact of our team and we’re just getting started, but they’re only possible because of the diverse talent, perspectives, and relentless drive of our team, and people like you.
Your Role in Our Mission
At Enveda, every role drives impact. As Clinical Development for Migraine, you won’t just run a study. ENV-308 isn’t another CGRP blocker. Its mechanism offers a fundamentally different entry point into migraine biology, addressing the metabolic and inflammatory underpinnings of migraine that current standards of care ignore. This role owns the migraine clinical story for ENV-308 - you will shape how the field thinks about migraine and prove it in public by mid-2027.
Similar jobs you might like
